Biosimilars for the Treatment of Retinal Diseases

被引：3
|
作者：
Hariprasad, Seenu M. [1 ]
Narayanan, Raja [2 ]
Sheth, Jay [3 ]
机构：
[1] Univ Chicago, Dept Ophthalmol & Visual Sci, 5841 S Maryland Ave,Room S-439, Chicago, IL 60637 USA
[2] LV Prasad Eye Inst, Smt Kanuri Santhamma Ctr Vitreoretinal Serv, Kallam Anji Reddy Campus,LV Prasad Marg,Opp PVR, Hyderabad 500034, Telangana, India
[3] Surya Eye Inst & Res Ctr, Dept Vitreoretinal Serv, Aroto House,104,Purushottam Kheraj Rd, Mumbai 400080, Maharashtra, India
来源：
OPHTHALMIC SURGERY LASERS & IMAGING RETINA | 2021年 / 52卷 / 05期
关键词：
LESSONS;
D O I：
10.3928/23258160-20210429-01
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
[No abstract available]
引用
下载
收藏
页码：242 / 246
页数：5
相关论文
共 50 条
  • [21] Clinical and Socioeconomic Burden of Retinal Diseases: Can Biosimilars Add Value? A Narrative Review
    Seenu M. Hariprasad
    Frank G. Holz
    Carl V. Asche
    Amine Issa
    Oriol Mora
    Simon Keady
    Mourad F. Rezk
    Phil Sarocco
    Steven Simoens
    Ophthalmology and Therapy, 2025, 14 (4) : 621 - 641
  • [22] Exosomes for the treatment of retinal diseases
    Lee, Sun Young
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [23] Retinoids for treatment of retinal diseases
    Palczewski, Krzysztof
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2010, 31 (06) : 284 - 295
  • [24] Photobiomodulation for the Treatment of Retinal Injury and Retinal Degenerative Diseases
    Eells, Janis T.
    DeSmet, Kristina D.
    Kirk, Diana K.
    Wong-Riley, Margaret
    Whelan, Harry T.
    Hoeve, James Ver
    Nork, T. Michael
    Stone, Jonathan
    Valter, Krisztina
    PROCEEDINGS OF LIGHT-ACTIVATED TISSUE REGENERATION AND THERAPY CONFERENCE, 2008, 12 : 39 - +
  • [25] Retinal transplantation - A treatment strategy for retinal degenerative diseases
    Thomas, BB
    Aramant, RB
    Sadda, SR
    Seiler, MJ
    RETINAL DEGENERATIVE DISEASES, 2006, 572 : 367 - 376
  • [26] Biosimilars for the Treatment of Chronic Inflammatory Diseases: A Systematic Review of Published Evidence
    Jacobs, Ira
    Petersel, Danielle
    Isakov, Leah
    Lula, Sadiq
    Sewell, K. Lea
    BIODRUGS, 2016, 30 (06) : 525 - 570
  • [27] Addressing unmet clinical needs: the potential of biosimilars in the treatment of rheumatic diseases
    Schulze-Koops, Hendrik
    RHEUMATOLOGY, 2017, 56 : 1 - 3
  • [28] Biosimilars for the Treatment of Chronic Inflammatory Diseases: A Systematic Review of Published Evidence
    Ira Jacobs
    Danielle Petersel
    Leah Isakov
    Sadiq Lula
    K. Lea Sewell
    BioDrugs, 2016, 30 : 525 - 570
  • [29] CONSENSUS RECOMMENDATIONS ON THE USE OF BIOSIMILARS IN THE TREATMENT OF INFLAMMATORY RHEUMATIC JOINT DISEASES
    Alnaqbi, K.
    Al Adhoubi, N.
    Al Dallal, S.
    Al Emadi, S.
    Al-Herz, A.
    El Shamy, A.
    Hannawi, S.
    Omair, M. A.
    Saad, S.
    Kvien, T. K.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 2025 - 2026
  • [30] Preparing for the next decade of anti-VEGF biosimilars for retinal diseases: a focus on South Asia
    Sharma, Ashish
    Kumar, Nilesh
    Parachuri, Nikulaa
    Loewenstein, Anat
    Bandello, Francesco
    Kuppermann, Baruch D.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, 23 (08) : 689 - 692
12345